ONCO Relative Valuation
ONCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ONCO is overvalued; if below, it's undervalued.
Historical Valuation
Onconetix Inc (ONCO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.41. The fair price of Onconetix Inc (ONCO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：2.95
Fair
-0.00
PE
1Y
3Y
5Y
Trailing
Forward
-0.14
EV/EBITDA
Onconetix Inc. (ONCO) has a current EV/EBITDA of -0.14. The 5-year average EV/EBITDA is -2.46. The thresholds are as follows: Strongly Undervalued below -21.63, Undervalued between -21.63 and -12.04, Fairly Valued between 7.13 and -12.04, Overvalued between 7.13 and 16.72, and Strongly Overvalued above 16.72. The current Forward EV/EBITDA of -0.14 falls within the Historic Trend Line -Fairly Valued range.
-0.20
EV/EBIT
Onconetix Inc. (ONCO) has a current EV/EBIT of -0.20. The 5-year average EV/EBIT is -2.17. The thresholds are as follows: Strongly Undervalued below -17.72, Undervalued between -17.72 and -9.95, Fairly Valued between 5.60 and -9.95, Overvalued between 5.60 and 13.38, and Strongly Overvalued above 13.38. The current Forward EV/EBIT of -0.20 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Onconetix Inc. (ONCO) has a current PS of 0.00. The 5-year average PS is 10.65. The thresholds are as follows: Strongly Undervalued below -70.60, Undervalued between -70.60 and -29.97, Fairly Valued between 51.27 and -29.97, Overvalued between 51.27 and 91.90, and Strongly Overvalued above 91.90. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.18
P/OCF
Onconetix Inc. (ONCO) has a current P/OCF of -0.18. The 5-year average P/OCF is -3.24. The thresholds are as follows: Strongly Undervalued below -27.23, Undervalued between -27.23 and -15.24, Fairly Valued between 8.76 and -15.24, Overvalued between 8.76 and 20.76, and Strongly Overvalued above 20.76. The current Forward P/OCF of -0.18 falls within the Historic Trend Line -Fairly Valued range.
-0.18
P/FCF
Onconetix Inc. (ONCO) has a current P/FCF of -0.18. The 5-year average P/FCF is -2.87. The thresholds are as follows: Strongly Undervalued below -23.74, Undervalued between -23.74 and -13.30, Fairly Valued between 7.56 and -13.30, Overvalued between 7.56 and 17.99, and Strongly Overvalued above 17.99. The current Forward P/FCF of -0.18 falls within the Historic Trend Line -Fairly Valued range.
Onconetix Inc (ONCO) has a current Price-to-Book (P/B) ratio of 1.36. Compared to its 3-year average P/B ratio of 0.37 , the current P/B ratio is approximately 271.17% higher. Relative to its 5-year average P/B ratio of 4.34, the current P/B ratio is about -68.56% higher. Onconetix Inc (ONCO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -445.17%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -354.27% , the current FCF yield is about -100.00% lower.
1.36
P/B
Median3y
0.37
Median5y
4.34
-160.92
FCF Yield
Median3y
-445.17
Median5y
-354.27
Competitors Valuation Multiple
The average P/S ratio for ONCO's competitors is 0.00, providing a benchmark for relative valuation. Onconetix Inc Corp (ONCO) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of -25.37%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ONCO decreased by 94.49% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -940.72 to -2.89K.
The secondary factor is the Revenue Growth, contributed -25.37%to the performance.
Overall, the performance of ONCO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Onconetix Inc (ONCO) currently overvalued or undervalued?
What is Onconetix Inc (ONCO) fair value?
How does ONCO's valuation metrics compare to the industry average?
What is the current P/B ratio for Onconetix Inc (ONCO) as of Dec 05 2025?
What is the current FCF Yield for Onconetix Inc (ONCO) as of Dec 05 2025?
What is the current Forward P/E ratio for Onconetix Inc (ONCO) as of Dec 05 2025?